Найкращі діагности з лікування КТ усього тіла – ТОП-48 лікарів

Work and Interest Areas

• Peripheral Arterial Diseases
• Neurovascular Interventions
• Oncologic Interventions
• Nonvascular Interventions

Education

• (2004 – 2011), Faculty of Medicine, Inonu University, Malatya, Turkey
• (2011 – 2015), Department of Radiology, Bagcilar Training and Research Hospital, Istanbul, Turkey

Experience

• (2016 – 2020), Diagnostic and Interventional Radiologist, Mus State Hospital, Mus, Turkey
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology, Sakarya University Training and Research Hospital, Sakarya, Turkey
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology, Sakarya University Training and Research Hospital, Sakarya, Turkey
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology, Medipol University Hospital, Istanbul, Turkey

Memberships in Scientific Organizations

• TSIR (Turkish Society of Interventional Radiology)
• TSR (Turkish Society of Radiology)
• CIRSE (Cardiovascular and Interventional Radiological Society of Europe)
• ESR (European Society of Radiology)
• ESNR (European Society of Neuroradiology)

Was born in 1981 in Erzincan. After finishing Beşiktaş Atatürk Anadolu High School in 1999 entered Istanbul University Çapa, Faculty of Medicine. 

In 2005 I got his Master Degree and started as a practitioner at Yüksekova State Hospital. He got his Doctorate at Okmeydanı Training and Research Hospital in General Surgery department. As a General Surgery Specialist, he worked at Zonguldak Atatürk State Hospital for 5 years and at Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital for 3 years. 

Worked as an Assistant Professor at Istanbul Medipol University, Department of General Surgery. Currently working at Medipol University Pendik Hospital. 

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Experience:

2022 - 

Medipol Bahçelievler

2021 - 2022

MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL

2018 - 2020

İSTİNYE UNIVERSITY FACULTY OF MEDICINE

2014 - 2020

TOKAT STATE HOSPITAL

2010 - 2010

BINGOL STATE HOSPITAL

Education:

2021

MEDIPOL UNIVERSITY, GASTROTEROLOGY

2018

İSTINYE UNIVERSITY, INTERNAL DISEASES USA

2014

ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY

2010

FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT

2004

FIRAT UNIVERSITY, FACULTY OF MEDICINE

A. International Peer-Reviewed Journal Articles:

Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.

• Authors: Sarıkaya Murat, Koçak Erdem, Köklü Seyfettin, Babalı Ayşegül, Çakal Başak
• Journal: Acta Gastro-Enterologica Belgica
• Year: 2012
• Volume/Issue: (Kontrol No: 1206043)

Title: Acute gastric obstruction resulting from gallstone-induced bezoar.

• Authors: Sarıkaya Murat, Koçak Erdem, Köklü Seyfettin, Akbal Erdem
• Journal: The American Surgeon
• Year: 2012
• Volume/Issue: 78(12)
• Page: 529
• (Kontrol No: 1129707)

Title: Garlic-induced esophagitis.

• Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
• Journal: Acta Gastro-Enterologica Belgica
• Year: 2013
• Volume/Issue: 76(2)
• Page: 262
• (Kontrol No: 1131422)

Title: Association between Helicobacter pylori and liver-to-spleen ratio.

• Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
• Journal: European Journal of Gastroenterology & Hepatology
• Year: 2013
• Volume/Issue: 25(1)
• Pages: 107-110
• Citations: 7
• DOI: 10.1097/MEG.0b013e3283590c10
• (Kontrol No: 1131424)

Title: Crohn's disease masked by median arcuate ligament syndrome.

• Authors: Bıyıkoğlu İbrahim, Sarıkaya Murat, Uysal Ramadan Selma, Ergül Bilal, Doğan Zeynal
• Journal: Chinese Medical Journal
• Year: 2013
• Volume/Issue: 126 (14)
• Page: 2798
• Citations: 1
• (Kontrol No: 1131477)

Title: Telaprevir and anemia: What we learned from the first three patients.

• Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
• Journal: Scandinavian Journal of Infectious Diseases
• Year: 2013
• Volume/Issue: 45(7)
• Page: 575-575
• Citations: 2
• DOI: 10.3109/00365548.2012.759271
• (Kontrol No: 1129738)

Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.

• Authors: Sarıkaya Murat, Filik Levent, Ergul Bilal, Doğan Zeynal
• Journal: Gastroenterology Nursing
• Year: 2013
• Volume/Issue: 36 (2)
• Pages: 145-148
• DOI: 10.1097/SGA.0b013e31828d3753
• (Kontrol No: 1129715)

Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?

• Authors: Ergül Bilal, Sarıkaya Murat, Doğan Zeynal, Filik Levent, Bıyıkoğlu İbrahim
• Journal: Digestive Endoscopy
• Year: 2013
• Volume/Issue: 25(1)
• Pages: 90-91
• Citations: 2
• DOI: 10.1111/j.1443-1661.2012.01383.x
• (Kontrol No: 1129879)

Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.

• Authors: Sarıkaya Murat, Filik Levent, Doğan Zeynal, Ergül Bilal
• Journal: Gastroenterology Nursing
• Year: 2013
• Volume/Issue: 36(2)
• Pages: 141-144
• DOI: 10.1097/SGA.0b013e31828d33db
• (Kontrol No: 1129712)

Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."

• Authors: Bilal Ergül, Murat Sarıkaya, Zeynal Doğan, Sevda İdil, Tarkan Karakan, Abdullah Çetin Köseoğlu
• Journal: Case Reports in Gastrointestinal Medicine
• Year: 2013
• Volume/Issue: 2013
• Article ID: 725434
• DOI: 10.1155/2013/725434
• (Kontrol No: 1131423)

Title: Severe acute pancreatitis due to hypertriglyceridemia.

• Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Bıyıkoğlu İbrahim
• Journal: Case Reports in Gastrointestinal Medicine
• Year: 2013
• Volume/Issue: 2013
• Article ID: 945902
• DOI: 10.1155/2013/945902
• (Kontrol No: 1131425)

Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.

• Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Sevda İdil
• Journal: Case Reports in Medicine
• Year: 2013
• Volume/Issue: 2013
• Article ID: 652960
• DOI: 10.1155/2013/652960
• (Kontrol No: 1131426)

Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.

• Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
• Journal: Case Reports in Gastrointestinal Medicine
• Year: 2013
• Volume/Issue: 2013
• Article ID: 604820
• DOI: 10.1155/2013/604820
• (Kontrol No: 1131427)

Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.

• Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
• Journal: Turkish Journal of Gastroenterology
• Year: 2013
• Volume/Issue: 24(3)
• Pages: 276-280
• DOI: 10.4318/tjg.2013.0565
• (Kontrol No: 1129727)

Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.

• Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Tarkan Karakan
• Journal: Case Reports in Gastrointestinal Medicine
• Year: 2013
• Volume/Issue: 2013
• Article ID: 658370
• DOI: 10.1155/2013/658370
• (Kontrol No: 1131475)

Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.

• Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
• Journal: Case Reports in Gastrointestinal Medicine
• Year: 2013
• Volume/Issue: 2013
• Article ID: 925259
• DOI: 10.1155/2013/925259
• (Kontrol No: 1131476)

B. Contributions to Scientific Conferences:

Title: Suicidal poisonings in Turkey: demographic and clinical aspects.

• Authors: Sarikaya M., Gunes A., Goksu E., Erdogan G., Ozen C., Kaya A.
• Conference: 30th European Congress of Clinical Toxicology (EAPCCT)
• Year: 2000
• Abstract ID: P44
• (Kontrol No: 1131478)

Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.

• Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
• Conference: World Congress of Gastroenterology
• Year: 2013
• Abstract ID: P1367
• (Kontrol No: 1131479)

Experience

2021 - 2022

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2021 - 2022

Department of Radiation Oncology, Biruni University Faculty of Medicine

2020 - 2021

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2017 - 2020

Clinical Manager of Radiation Oncology, Neolife Medical Center

2016 - 2017

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2011 - 2016

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2010 - 2011

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2008 - 2010

Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

2006

Medical Faculty, Dokuz Eylül University

2006 - 2008

Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

2000 - 2006

Medical Faculty, Dokuz Eylül University

Education

2022

Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

2022

Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

2021

Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

2006

Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

2006

Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

1998

Ege University, Faculty of Medicine

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Доктор Ар'є Блашар - спеціалізований діагностичний радіолог, експерт у галузі візуалізації черевної порожнини, печінкової перфузії, КТ-колонографії, МРТ тіла та досвідчений у проведенні візуалізаційних досліджень органів черевної порожнини й таза. Він визнаний одним із найкращих викладачів Медичної школи Саклера Тель-Авівського університету і включений до списку найкращих лікарів країни за версією журналу Forbes Israel за 2021 рік.

Education

• (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
• (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

• (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye

Memberships

• Board member of the Hungarian Society of Radiologists, secretary general of the Breast Diagnostics Section, head of the French working group
   
• President of the European Society of Breast Diagnostics (EUSOBI).
• Member of the French Society of Radiologists
• Head of the Breast Diagnostics Committee of the European Society of Radiologists
• Member of the OTH/ÁNTSZ Breast Screening Working Group
• President of the Pro-Radiology Public Foundation
• Founding member of the Health Bridge Association Association

Prizes, awards and recognition

• Knight's Cross of the Order of Merit of the French Republic
• Hungarian Society of Radiologists Alexander Memorial Medal Hungarian Society of Radiologists Zoltán Zsebők Memorial Medal
• French Society of Radiologists Herman Fischgold award Hungarian Society of Oncologists Liszka György award

International experience

• Nottingham National Breast Screening Training Centre, UK
• Hospital Tenon / Université Pierre et Marie Curie, Paris VI and INSEAD, Versailles, France
• Heinrich-Heine-Universität, Düsseldorf, Germany

Experience

1989 - 1990

Diyarbakır Kulp Merkez Sağlık Ocağı

1990

Selçuk University Faculty of Medicine

1995

Konya State Hospital

1995

Selçuk University Faculty of Medicine

1997

600-Bed Golcuk Naval Hospital

1999

Selçuk University Meram Faculty of Medicine

2005

Selçuk University Meram Faculty of Medicine

2011

Selçuk University Selçuklu Faculty of Medicine

2020

Özel Bower Hospital

Education

1994 Selçuk University, Thoracic Surgery

1989 Gazi University, Faculty of Medicine

1989 Gazi University, Faculty of Medicine

Experience

2019 - 2022 Medipol University

2010 Private Nisa Hospital

2008 - 2010 Kaman State Hospital

Education

2008

Istanbul University Cerrahpaşa Faculty of Medicine, Obstetrics and Gynecology

2002

Istanbul University, Istanbul Faculty of Medicine

Experience 

• 2016 - 2017

İSTİNYE UNIVERSITY FACULTY OF MEDICINE

• 2016 - 2017

Liv Hospital

• 2016 - 2017

Liv Hospital Ulus

• 2015 - 2016

Acıbadem Bodrum Hospital

• 2014 - 2015

Tatvan State Hospital

• 2013 - 2015

Tatvan State Hospital

• 2012 - 2013

CLEVELAND CLINIC

• 2007 - 2014

Dokuz Eylul University Faculty of Medicine

Education 

• 2013

DOKUZ EYLÜL UNIVERSITY FACULTY OF MEDICINE, FACULTY OF MEDICINE/DEPARTMENT OF SURGICAL MEDICAL SCIENCES/DEPARTMENT OF GENERAL SURGERY

• 2013

Dokuz Eylül University, General Surgery

• 2007

AKDENİZ UNIVERSITY, FACULTY OF MEDICINE

• 2007

International Peer-Reviewed Journal Articles:

Title: The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience.

• Authors: AĞALAR CİHAN, SÖKMEN SELMAN, ARSLAN ÖZŞAHİN NACİYE ÇİĞDEM, ALTAY CANAN, BAŞARA AKIN IŞIL, CANDA ARAS EMRE, OBUZ FUNDA
• Journal: Techniques in Coloproctology
• Year: 2020
• Volume: 24(4)
• Pages: 301-308
• DOI: 10.1007/s10151-020-02159-z
• Publication Number: 6776368

Title: Randomized controlled trial of 8 weeks’ vs 12 weeks’ interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer.

• Authors: Terzi Cem, Bingül Mustafa, ARSLAN NACİYE ÇİĞDEM, ÖZTÜRK ERSİN, CANDA ARAS EMRE, IŞIK ÖZGEN, YILMAZLAR AHMET TUNCAY, OBUZ FUNDA, Görken Birkay, KURT MERAL, ÜNLÜ ŞADİYE MEHTAT, UĞRAŞ NESRİN, Kanat Özkan, ÖZTOP İLHAN
• Journal: Colorectal Disease
• Year: 2020
• Volume: 22(3)
• Pages: 279-288
• DOI: 10.1111/codi.14867
• Publication Number: 6012919

Title: The effect of fibrin glue in preventing staple-line leak after sleeve gastrectomy: an experimental study in rats.

• Authors: ÖZDENKAYA YAŞAR, OLMUŞÇELİK OKTAY, BASIM PELİN, SAKA BURCU, ARSLAN NACİYE ÇİĞDEM
• Journal: Acta Cirurgica Brasileira
• Year: 2019
• Volume: 34(8)
• Publication Number: 5242669

Title: Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.

• Authors: CANDA ARAS EMRE, ARSLAN NACİYE ÇİĞDEM, Terzi Cem, Sokmen Selman, YAVUZŞEN TUĞBA, Ozkardesler Sevda, Unlu Mehtat, OBUZ FUNDA, FÜZÜN MEHMET
• Journal: World Journal of Surgical Oncology
• Year: 2018
• Volume: 16(1)
• Pages: 70-74
• DOI: 10.1186/s12957-018-1369-7
• Publication Number: 4863133

Title: Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid–low rectal cancer.

• Authors: Atasoy Gulsen, ARSLAN NACİYE ÇİĞDEM, Elibol Funda, SAĞOL ÖZGÜL, OBUZ FUNDA, SÖKMEN SELMAN
• Journal: Surgery Today
• Year: 2018
• Volume: 48(12)
• Pages: 1040-1051
• DOI: 10.1007/s00595-018-1690-3
• Publication Number: 4863005

Title: Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?

• Authors: Terzi Cem, Sokmen Selman, ARSLAN NACİYE ÇİĞDEM, Ozkardesler Sevda, DURAL CEMIL, OBUZ FUNDA, CANDA ARAS EMRE, GÖKTÜRK ÜMIT KELEŞTEN
• Journal: International Journal of Surgery
• Year: 2018
• Volume: 51
• Pages: 156-160
• DOI: 10.1016/j.ijsu.2018.01.010
• Publication Number: 4855751

Contributions to Conferences:

Title: Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A single-center experience.

• Authors: CANDA ARAS EMRE, Sokmen Selman, Terzi Cem, ARSLAN NACİYE ÇİĞDEM, OBUZ FUNDA
• Conference: European Society of Surgical Oncology (ESSO) Congress
• Year: 2018
• Location: Budapest, Hungary

Title: Predictive factors for conversion to open surgery in laparoscopic colorectal surgery.

• Authors: ARSLAN NACİYE ÇİĞDEM, Terzi Cem, Sokmen Selman, CANDA ARAS EMRE, OBUZ FUNDA
• Conference: European Association for Endoscopic Surgery (EAES) Congress
• Year: 2017
• Location: Frankfurt, Germany

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Experience

2017 - 2019 Okan Üniversitesi Hastanesi

2019 - Medipol University Pendik Hospital

Education

2016 Marmara Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları

2007 Aziz Kiril ve Metodiy Üniversitesi, Tıp Fakültesi

Publications

1- Yetişkin Kistik Fibrozis Dışı Bronşektazi Hastalarında İmmün Yetmezlik Sıklığı ; Uzmanlık Tezi

2- Canan Cimşit, Melahat Bekir, Sait Karakurt, Emel Eryüksel, KOAH’ta diyafram kalınlığının ultrasonografi ile değerlendirilmesi – Marmara Medical Journal 2016; 29:8-13

3- Emel Eryuksel, Canan Cimsit , Melahat Bekir, Çagatay Cimsit , Sait Karakurt, Diaphragmatic Thickness Fraction in Subjects at High Risk for COPD Exacerbations Respiratory Care December 2017

4- Melahat Bekir ,T. Bahadır Üskül, Pulmonary Functions in Patients With Idiopathic Scoliosis The Journal of Turkish Spinal Surgery ; April 2017

5- Emel Eryuksel , Canan Cimsit, Melahat Bekir, Cagatay Cimşit, Sait Karakurt, Is Diaphragmatic Thickness fraction valuable in Identifying High- Risk Chronic Obstructive Pulmonary Disease Patients , European Respiratory Journal Sep 2017

6- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Berrin Ceyhan, Kistik Fibrozis Dışı Erişkin Bronşektazi Hastalarında Klinik Bulguların Bir Yıllık Hastalık Seyrine Etkisi Türk Toraks Derneği 21. Yıllık Kongresi _ Belek, Türkiye 2018

7- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli Derya Kocakaya, Emel Eryüksel, Elif Karakoç Aydıner, İsmail Öğülür, Berrin Bağcı Ceyhan, Kistik Fibrozis Dışı Erişkin Bronşektazi Hastalarında Yaşam Kalitesi : Psikolojik durum ve Hastalık Şiddetinin Rolü Türk Toraks Derneği 20. Yıllık Kongresi – Belek Türkiye 2017

8- Berrin Ceyhan, Melahat Bekir, Şehnaz olgun Yıldızeli, Derya Kocakaya , Emel Eryüksel, EMBARC ( Eurpean Bronchiectasis Audit and Reserach Collaboration) yaşam kalitesi ölçeğinin Türkçe versiyonunun kistik fibrozis dışı bronşektazi hastarında geçerlik ve güvenirliği Türk Toraks Derneği 20. Yıllık Kongresi – Belek, Türkiye 2017 ( POSTER ÖDÜLLÜ)

9- Melahat Bekir, Şehnaz Olgun Yıldizeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Beyhan , Yetişkin Non Kistik Fibrozis Bronşektazi Hastalarında Vitamin D düzeyi ile Akciğer Fonksiyonları, Klinik İndeksler, Anksiyete- Depresyon Semptomları Arasındaki İlişki – Türk Toraks Derneği 19. Yıllık Kongresi - Belek, Türkiye 2016

10- Melahat Bekir, Derya Kocakaya , Şehnaz Olgun , Berrin Bağcı Ceyhan , Aktif Kanaması Olan Vena Cava Superior Sendromuna Yol Açan Venöz Tromboz Olgusunda Antikoagülan Tedavi Yaklaşımı – Türk Toraks Derneği 18. Yıllık Kongresi – Belek, Türkiye 2015

11- Melahat Bekir, Berrin Bağcı Ceyhan, Rivaroxaban ile Antikoagülasyon Sonrası Gelişen Hayattı Tehdit Eden Kanamalar : İki Olgu Sunumu , Türk Toraks Derneği 18. Yıllık Kongresi – Belek, Türkiye 2015

12- Şehnaz Olgun Yıldızeli, Çagatay Nuri Cimşit, Semiha Emel Eryüksel, Canan Cimşit, Melahat Bekir, Tuğçe Yakut, Pulmoner Embolide Pulmoner BT Anjionun Klinik Skorlamalar ile İlişkisi – Türk Toraks Derneği 18. Yıllık Kongresi – Belek Türkiye 2015

13- Melahat Bekir, Canan Cimşit, Hüseyin Arıkan, Derya Kocakaya, Şehnaz,Olgun, Semiha Emel Eryüksel, Sait Karakurt, KOAH Hastalarında Diyafram Kalınlığı ve Semptomlarla İlişkisi, Türk Toraks Derneği 17. Yıllık Kongresi – Belek, Türkiye 2014

14- Melahat Bekir Külah, Kistik Fibrozis Dışı Bronşektazi Hastalarında İmmün yetmezlik Sıklığı ve Klinik Parametrelerle İlişkisi Türk Toraks Derneği 20. Yıllık Kongresi – Belek Türkiye 2017

15- Berrin Ceyhan, Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya , One Year Follow-Up of respiratory Health Outcomes in adult patiens with Non- Cystic Fibrosis Bronchiectasis ERS 2018

16- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Emel Eryüksel, Elif Karakoç, İsmail Öğülür Berrin Bağcı Ceyhan Immun Deficiency in Patients with Non Cystic Fibrosis Bronchiectasis and Relationship with Clinical Parameters ATS Conference 2017- Washington, DC 2017

17- Melahat Bekir Külah, Sehnaz Olgun Yildizeli, Derya Kocakaya, Emel Eryuksel, Berrin Bagci Ceyhan Health Related Quality of Life Among Adult Patients With non Cf Bronchiectasis : The Role of Psychological status and disease severity ERS İnternatıonal Congress 2017 , Milan Italy 2017

18- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Ceyhan The Relationship Between Vitamin D Level and Lunf Fonction, Severity and Clinical Indices, Depression and Anxiety Symptoms in Adult Patients With Non- Cystic Fibrosis Bronchiectasis ATS Conference 2016 - San Francisco , California 2016